Ultralife (NASDAQ:ULBI) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.21 by 95.24 percent. The company reported quarterly sales of $35.700 million which missed the analyst consensus estimate of $43.000 million by 16.98 percent. This is a 9.59 percent decrease over sales of $39.488 million the same period last year.